Successful resection of port site recurrence of pancreatic ductal adenocarcinoma after laparoscopic distal pancreatectomy.

Laparoscopic surgery Pancreatic ductal adenocarcinoma Port site recurrence

Journal

Surgical case reports
ISSN: 2198-7793
Titre abrégé: Surg Case Rep
Pays: Germany
ID NLM: 101662125

Informations de publication

Date de publication:
03 Mar 2023
Historique:
received: 26 12 2022
accepted: 10 02 2023
entrez: 3 3 2023
pubmed: 4 3 2023
medline: 4 3 2023
Statut: epublish

Résumé

There are many reports of port site recurrence after laparoscopic surgery for various types of cancer. However, only two cases of port site recurrence after laparoscopic pancreatectomy have been reported to date. We herein report a case of port site recurrence after laparoscopic distal pancreatectomy. A 73-year-old woman was diagnosed with pancreatic tail cancer and underwent laparoscopic distal pancreatectomy with splenectomy. Histopathological examination revealed pancreatic ductal carcinoma (pT1N0M0 pStage I). The patient was discharged on postoperative day 14 with no complications. However, 5 months after surgery, computed tomography showed a small tumor at the right abdominal wall. No distant metastasis had appeared after 7 months of follow-up. Under the diagnosis of port site recurrence without any other metastases, we resected this abdominal tumor. Histopathological examination showed port site recurrence of pancreatic ductal carcinoma. No recurrence was observed 15 months postoperatively. This is the report of successful resection of port site recurrence of pancreatic cancer.

Sections du résumé

BACKGROUND BACKGROUND
There are many reports of port site recurrence after laparoscopic surgery for various types of cancer. However, only two cases of port site recurrence after laparoscopic pancreatectomy have been reported to date. We herein report a case of port site recurrence after laparoscopic distal pancreatectomy.
CASE PRESENTATION METHODS
A 73-year-old woman was diagnosed with pancreatic tail cancer and underwent laparoscopic distal pancreatectomy with splenectomy. Histopathological examination revealed pancreatic ductal carcinoma (pT1N0M0 pStage I). The patient was discharged on postoperative day 14 with no complications. However, 5 months after surgery, computed tomography showed a small tumor at the right abdominal wall. No distant metastasis had appeared after 7 months of follow-up. Under the diagnosis of port site recurrence without any other metastases, we resected this abdominal tumor. Histopathological examination showed port site recurrence of pancreatic ductal carcinoma. No recurrence was observed 15 months postoperatively.
CONCLUSIONS CONCLUSIONS
This is the report of successful resection of port site recurrence of pancreatic cancer.

Identifiants

pubmed: 36867254
doi: 10.1186/s40792-023-01607-w
pii: 10.1186/s40792-023-01607-w
pmc: PMC9984651
doi:

Types de publication

Journal Article

Langues

eng

Pagination

35

Informations de copyright

© 2023. The Author(s).

Références

Surg Endosc. 1996 Aug;10(8):809-12
pubmed: 8694943
Gan To Kagaku Ryoho. 2011 Nov;38(12):2454-6
pubmed: 22202411
Surg Case Rep. 2020 May 11;6(1):98
pubmed: 32394301
Trends Cell Biol. 2019 Mar;29(3):212-226
pubmed: 30594349
Pathology. 2007 Jun;39(3):305-18
pubmed: 17558857
Am J Surg. 2004 Jun;187(6):705-12
pubmed: 15191862
Mol Cancer. 2010 Jul 07;9:179
pubmed: 20609236
Dev Cell. 2018 Jun 18;45(6):681-695.e4
pubmed: 29920274
Int J Gynaecol Obstet. 2008 May;101(2):199
pubmed: 18215661
Clin Exp Metastasis. 2008;25(6):621-8
pubmed: 18600305
J Cell Biol. 2006 Mar 27;172(7):973-81
pubmed: 16567498
Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1540-7
pubmed: 25794828
Surg Oncol. 2019 Jun;29:20-24
pubmed: 31196489
Surg Today. 2017 Mar;47(3):280-283
pubmed: 27226019
J Gastrointest Surg. 2012 Dec;16(12):2294-6
pubmed: 23093448
J Laparoendosc Adv Surg Tech A. 2020 Oct;30(10):1090-1094
pubmed: 32282270
Cancers (Basel). 2021 Dec 07;13(24):
pubmed: 34944773
Indian J Surg Oncol. 2018 Sep;9(3):427-431
pubmed: 30288012
Biomedicines. 2022 May 31;10(6):
pubmed: 35740311
Surgery. 2017 Mar;161(3):618-627
pubmed: 27743715
Surg Endosc. 2000 Nov;14(11):1034-6
pubmed: 11116413
Curr Opin Cell Biol. 2003 Dec;15(6):740-6
pubmed: 14644200
World J Surg. 1999 Oct;23(10):989-95; discussion 996-7
pubmed: 10512937
Surg Today. 1999;29(1):71-5
pubmed: 9934836
Clin J Gastroenterol. 2021 Dec;14(6):1626-1631
pubmed: 34537922
Mol Oncol. 2017 Jul;11(7):718-738
pubmed: 28590039
Indian J Surg Oncol. 2019 Mar;10(1):37-39
pubmed: 30948869

Auteurs

Takashi Aida (T)

Department of Surgery, The Jikei University Katsushika Medical Center, 6-41-2, Aoto, Katsushika-Ku, Tokyo, 125-8506, Japan.

Ryota Iwase (R)

Department of Surgery, The Jikei University Katsushika Medical Center, 6-41-2, Aoto, Katsushika-Ku, Tokyo, 125-8506, Japan.

Teruyuki Usuba (T)

Department of Surgery, The Jikei University Katsushika Medical Center, 6-41-2, Aoto, Katsushika-Ku, Tokyo, 125-8506, Japan.

Yu Kumagai (Y)

Department of Surgery, The Jikei University Katsushika Medical Center, 6-41-2, Aoto, Katsushika-Ku, Tokyo, 125-8506, Japan.

Kenei Furukawa (K)

Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The Jikei University School of Medicine, 3-25-8, Nishi-Shinbashi, Minato-Ku, Tokyo, 105-8461, Japan. k-furukawa@jikei.ac.jp.

Shinji Onda (S)

Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The Jikei University School of Medicine, 3-25-8, Nishi-Shinbashi, Minato-Ku, Tokyo, 105-8461, Japan.

Masaichi Ogawa (M)

Department of Surgery, The Jikei University Katsushika Medical Center, 6-41-2, Aoto, Katsushika-Ku, Tokyo, 125-8506, Japan.

Toru Ikegami (T)

Division of Hepatobiliary and Pancreatic Surgery, Department of Surgery, The Jikei University School of Medicine, 3-25-8, Nishi-Shinbashi, Minato-Ku, Tokyo, 105-8461, Japan.

Classifications MeSH